Curi Bio used its 3D human iPSC-derived neuromuscular junction model on Mantarray™ to run an exercise protocol optimized by machine learning and measure contractility through the synapse itself via optogenetic activation of motor neurons expressing ChR2.
Published
Signal category
Research & Knowledge
Quote
“Using Curi Bio's 3D human iPSC-derived neuromuscular junction (NMJ) model on Mantarray™, we ran an exercise protocol optimized by machine learning and measured contractility through the synapse itself, via optogenetic activation of motor neurons expressing ChR2.”
— Curi Bio team
Company
Curi Bio
Human Data for Next Generation Medicines
- Industry
- Biotechnology Research
- Location
- Seattle, US
- Company size
- 56 employees
"Human Data for Next Generation Medicines" Curi Bio unlocks novel workflows and critical human data to inform R&D decision-making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges functional and analytical assessments for drug safety, efficacy, and potency
Founded 2015